Search for " " - Xconomy

Results for “ ”

Entry	Author	Date	Location
Calporta, Started by Avalon Ventures-GSK, Is Acquired by Merck	Sarah de Crescenzo	11/13/19	San Diego
Avidity Bio Adds $100M to Advance R&D of Muscle Disorder Drugs	Frank Vinluan	11/13/19	San Diego
Roche Challenger to Biogen’s SMA Drug Succeeds in Pivotal Study	Frank Vinluan	11/11/19	National
Neuroscience Is Taking the Spotlight at Xconomy’s Bay Area Xchange	Frank Vinluan	11/11/19	San Francisco
Looking to Level Up in NASH, Novo Nordisk Licenses Ube Drug Candidate	Sarah de Crescenzo	11/08/19	National
Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More	Frank Vinluan	11/08/19	National
3 Changes We Should Make to Address the Gender Pay Gap in Medicine	Alex Harding	11/06/19	Boston
AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund	Gareth Macdonald	11/06/19	National
GE Healthcare Opens Startup Labs at Former AstraZeneca UK R&D Site	Dan Stanton	11/06/19	National
Why Steve Kafka Left Third Rock Ventures for Up-and-Comer Section 32	Sarah de Crescenzo	11/05/19	San Diego
With $9.5M, Intrepida Bio Launches to Target Pancreatic Cancer & More	Sarah de Crescenzo	11/04/19	San Diego
Halozyme to Restructure After Pancreatic Cancer Drug Fails in Phase 3	Frank Vinluan	11/04/19	San Diego
Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More	Frank Vinluan	11/01/19	National
FDA Halts Novartis Gene Therapy Study Amid Animal Safety Concerns	Frank Vinluan	10/30/19	National
UK Regulator Has “Competition Concerns” Over Illumina-PacBio Tie-Up	Sarah de Crescenzo	10/25/19	San Diego
Bio Roundup: Biogen’s Reversal, FDA Moves Fast, a CF Cocktail & More	Sarah de Crescenzo	10/25/19	National
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More	Frank Vinluan	10/18/19	National
Plexium Debuts With $28M and a New Take on Protein Degradation Drugs	Sarah de Crescenzo	10/17/19	San Diego
Healx Bags $56M to Advance Affordable, AI-Based Orphan Drugs	Mike Ward	10/17/19	National
Bio Roundup: Nobel Prizes, Placebo Effect Rises, ICER’s Fire & More	Alex Lash	10/11/19	National
The Placebo Effect Is Hobbling New Psychiatric Drugs. What Can Stop It?	Alex Lash	10/10/19	National
Five Years After Y Combinator First Admits Biotechs, They’re Dug In	Bernadette Tansey	10/09/19	San Francisco
LabFellows Looks to Become “Operating System” For Life Sciences Cos.	Sarah de Crescenzo	10/08/19	San Diego
Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels	Frank Vinluan	10/07/19	National
Precision IBD Rebrands as Prometheus and Strikes R&D Deal With Takeda	Sarah de Crescenzo	10/07/19	San Diego
Bio Roundup: PARP Progress, A New Commish, IPO-Palooza & More	Ben Fidler	10/04/19	National
After Brain Cancer Drug Fails, Tocagen to Cut More Than Half of Staff	Sarah de Crescenzo	10/03/19	San Diego
Nuance Spinout Cerence Vies With Tech Giants in Voice-AI for Auto	Bernadette Tansey	10/02/19	San Francisco
Viscient Bio Proposes Organovo Merger to Tackle NASH and Go Beyond	Frank Vinluan	10/02/19	San Diego
Molecular Assemblies Raises $12M to Advance Enzymatic DNA Synthesis	Sarah de Crescenzo	10/01/19	San Diego
Page 1 of 337	next page »